These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28004516)

  • 41. Atomic basis for the species-specific inhibition of αV integrins by monoclonal antibody 17E6 is revealed by the crystal structure of αVβ3 ectodomain-17E6 Fab complex.
    Mahalingam B; Van Agthoven JF; Xiong JP; Alonso JL; Adair BD; Rui X; Anand S; Mehrbod M; Mofrad MR; Burger C; Goodman SL; Arnaout MA
    J Biol Chem; 2014 May; 289(20):13801-9. PubMed ID: 24692540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Size-Dependent Cellular Uptake of RGD Peptides.
    Kemker I; Feiner RC; Müller KM; Sewald N
    Chembiochem; 2020 Feb; 21(4):496-499. PubMed ID: 31478590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins.
    Takagi J
    Biochem Soc Trans; 2004 Jun; 32(Pt3):403-6. PubMed ID: 15157147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity.
    Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A
    Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relative orientation of the Arg and Asp side chains defined by a pseudodihedral angle as a key criterion for evaluating the structure-activity relationship of RGD peptides.
    Kostidis S; Stavrakoudis A; Biris N; Tsoukatos D; Sakarellos C; Tsikaris V
    J Pept Sci; 2004 Aug; 10(8):494-509. PubMed ID: 15347137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering.
    Guo Z; He B; Jin H; Zhang H; Dai W; Zhang L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2014 Jul; 35(23):6106-17. PubMed ID: 24794924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. α
    Catignas KK; Frick LR; Pellegatta M; Hurley E; Kolb Z; Addabbo K; McCarty JH; Hynes RO; van der Flier A; Poitelon Y; Wrabetz L; Feltri ML
    Glia; 2021 Jan; 69(1):91-108. PubMed ID: 32744761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.
    Salvati M; Cordero FM; Pisaneschi F; Melani F; Gratteri P; Cini N; Bottoncetti A; Brandi A
    Bioorg Med Chem; 2008 Apr; 16(8):4262-71. PubMed ID: 18343671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and function of RGD peptides derived from disintegrin proteins.
    Kim J; Hong SY; Park HS; Kim DS; Lee W
    Mol Cells; 2005 Apr; 19(2):205-11. PubMed ID: 15879703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined QM/MM study of thyroid and steroid hormone analogue interactions with αvβ3 integrin.
    Freindorf M; Furlani TR; Kong J; Cody V; Davis FB; Davis PJ
    J Biomed Biotechnol; 2012; 2012():959057. PubMed ID: 22547930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human α
    Borst AJ; James ZM; Zagotta WN; Ginsberg M; Rey FA; DiMaio F; Backovic M; Veesler D
    Structure; 2017 Nov; 25(11):1732-1739.e5. PubMed ID: 29033288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
    Conradi J; Huber S; Gaus K; Mertink F; Royo Gracia S; Strijowski U; Backert S; Sewald N
    Amino Acids; 2012 Jul; 43(1):219-32. PubMed ID: 21915696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorometric assay of integrin activity with a small-molecular probe that senses the binding site microenvironment.
    Komatsu T; Takeda A; Hanaoka K; Terai T; Ueno T; Tada Y; Nagano T; Urano Y
    Chem Commun (Camb); 2014 Dec; 50(100):15894-6. PubMed ID: 25376090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural Basis of the Differential Binding of Engineered Knottins to Integrins αVβ3 and α5β1.
    Van Agthoven JF; Shams H; Cochran FV; Alonso JL; Kintzing JR; Garakani K; Adair BD; Xiong JP; Mofrad MRK; Cochran JR; Arnaout MA
    Structure; 2019 Sep; 27(9):1443-1451.e6. PubMed ID: 31353240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of integrin β3 in PGE₂-stimulated adhesion of mastocytoma P-815 cells to the Arg-Gly-Asp-enriched fragment of fibronectin.
    Okada Y; Nishikawa J; Semma M; Ichikawa A
    Biochem Pharmacol; 2011 Apr; 81(7):866-72. PubMed ID: 21276770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.
    Sancey L; Lucie S; Garanger E; Elisabeth G; Foillard S; Stéphanie F; Schoehn G; Guy S; Hurbin A; Amandine H; Albiges-Rizo C; Corinne AR; Boturyn D; Didier B; Souchier C; Catherine S; Grichine A; Alexeï G; Dumy P; Pascal D; Coll JL; Jean-Luc C
    Mol Ther; 2009 May; 17(5):837-43. PubMed ID: 19259068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Connection between integrins and cell activation in rat adrenal glomerulosa cells: a role for Arg-Gly-Asp peptide in the activation of the p42/p44(mapk) pathway and intracellular calcium.
    Campbell S; Otis M; Côté M; Gallo-Payet N; Payet MD
    Endocrinology; 2003 Apr; 144(4):1486-95. PubMed ID: 12639933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor Targeting with an isoDGR-Drug Conjugate.
    Zanella S; Angerani S; Pina A; López Rivas P; Giannini C; Panzeri S; Arosio D; Caruso M; Gasparri F; Fraietta I; Albanese C; Marsiglio A; Pignataro L; Belvisi L; Piarulli U; Gennari C
    Chemistry; 2017 Jun; 23(33):7910-7914. PubMed ID: 28449309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand.
    Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG
    Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.